Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.

Details

Language :

English

ISSN :

20411723

Volume :

16

Issue :

1

Database :

Complementary Index

Journal :

Nature Communications

Publication Type :

Academic Journal

Accession number :

182253329

Full Text :

https://doi.org/10.1038/s41467-025-56170-9